SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.50-1.6%Nov 25 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (28656)4/5/1999 5:49:00 PM
From: bluejeans  Read Replies (2) of 32384
 
One of the value of acquiring almost defunct companies is their
tax significant carryover losses.

After a reorganization or other change in corporate ownership, the use of certain tax carry forwards may be limited. The amount of income that Ligand may offset each year by SRGN's net operating loss carry forward is generally limited to an amount determined by multiplying the value of the stock of SRGN just prior to the acquisition by the federal long-term tax exempt rate in effect at the time of acquisition.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News